GCG and type 2 diabetes mellitus: The increase in plasma active GLP-1 in our study resembles changes reported in type 2 diabetics after MMTT, while the rapid increase in plasma GIP in our study resembles the changes reported in pre-diabetic and diabetic patients following a MMTT challenge52.